CellCyte Genetics Corp names Dr. Douglas Pat Cerretti president
Sep. 29, 2010 (M2 Communications Ltd.) --
Biotechnology company CellCyte Genetics Corp (OTCBB:CCYG) reported on Tuesday that Douglas Pat Cerretti , Ph.D. has been appointed as president of the company.
Dr. Cerretti will also retain his responsibilities as chief science officer and director of business development.
Dr. Cerretti, a biopharmaceutical research scientist, has been involved with CellCyte as an independent consultant and, since November 2008, has helped refine its Interim Operating Plan.
From 1984 to 2002 Dr. Cerretti worked with Immunex and, after Immunex’s acquisition in 2002, with Amgen in positions ranging from staff scientist through to scientific director. He retired from Amgen in 2007.
(Comments on this story may be sent to info@m2.com)
Source: M2 Presswire (September 29, 2010 - 5:28 AM EDT)
News by QuoteMedia
www.quotemedia.com
